JOSÉ LUIS
DÍEZ MARTÍN
Profesor titular de universidad
Fundación Jiménez Díaz
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Fundación Jiménez Díaz (11)
2023
2021
-
Management of Donor-Specific Antibodies in Haploidentical Transplant: Multicenter Experience From the Madrid Group of Hematopoietic Transplant
Frontiers in Immunology, Vol. 12
-
Risk factors and mortality of COVID-19 in patients with lymphoma: A multicenter study
HemaSphere, Vol. 5, Núm. 3, pp. 1-8
-
Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT
Bone Marrow Transplantation, Vol. 56, Núm. 2, pp. 481-491
2020
-
Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: Lessons from a large population-based registry study
Journal of Hematology and Oncology, Vol. 13, Núm. 1
2018
-
Whole-exome sequencing reveals acquisition of mutations leading to the onset of donor cell leukemia after hematopoietic transplantation: a model of leukemogenesis
Leukemia, Vol. 32, Núm. 8, pp. 1822-1826
2015
-
Interobserver variance in myelodysplastic syndromes with less than 5 % bone marrow blasts: unilineage vs. multilineage dysplasia and reproducibility of the threshold of 2 % blasts
Annals of Hematology, Vol. 94, Núm. 4, pp. 565-573
2010
-
Rituximab is an effective and safe therapeutic alternative in adults with refractory and severe autoimmune hemolytic anemia
Annals of Hematology, Vol. 89, Núm. 11, pp. 1073-1080
2003
2002
-
Low transplant-related mortality after second allogeneic peripheral blood stem cell transplant with reduced-intensity conditioning in adult patients who have failed a prior autologous transplant
Bone Marrow Transplantation, Vol. 30, Núm. 2, pp. 63-68